NewGenIvf Group Limited (NIVFW)
NasdaqCM: NIVFW
· Real-Time Price · USD
0.02
+0.00 (0.00%)
At close: Aug 07, 2026, 2:41 PM
NewGenIvf Group Limited (NIVFW) Stock Price, Analysis & Data
0.00% (1D)
| Bid | 0.07 |
| Market Cap | n/a |
| Revenue (ttm) | 4.73M |
| Net Income (ttm) | 9.88M |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | n/a |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 0.04 |
| Volume | 5,150 |
| Avg. Volume (20D) | |
| Open | 0.03 |
| Previous Close | 0.02 |
| Day's Range | 0.02 - 0.02 |
| 52-Week Range | 0.02 - 0.02 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About NIVFW
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing...
IPO Date Jul 17, 2026
Employees 87
Stock Exchange NasdaqCM
Ticker Symbol NIVFW
Website https://www.nivf.global
Financial Performance
In 2025, NewGenIvf's revenue was 4.73M, a decrease of -13.01% compared to the previous year's 5.43M. Earnings were 9.88M, a decrease of -1,983.07%.
Financial Statements